No. 25A357
Boehringer Ingelheim Pharmaceuticals, Inc. v. Department of Health and Human Services, et al.
Tags: compelled-speech fifth-amendment first-amendment medicare-drug-negotiation price-setting takings-clause
Latest Conference:
N/A
Question Presented (from Petition)
Question not identified.
Question Presented (AI Summary)
Whether the Medicare Drug Price Negotiation Program's compulsory participation and price-setting mechanism constitutes an unconstitutional taking or compelled speech in violation of the Fifth and First Amendments
Docket Entries
2025-09-29
Application (25A357) granted by Justice Sotomayor extending the time to file until January 5, 2026.
2025-09-25
Application (25A357) to extend the time to file a petition for a writ of certiorari from November 5, 2025 to January 4, 2026, submitted to Justice Sotomayor.
Attorneys
United States Department of Health and Human Services, et al.
D. John Sauer — Solicitor General, Respondent